These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33439998)

  • 41. Adverse outcomes associated with rapid linear and non-linear patterns of chronic kidney disease progression.
    Ali I; Chinnadurai R; Ibrahim ST; Kalra PA
    BMC Nephrol; 2021 Mar; 22(1):82. PubMed ID: 33676423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies.
    Minutolo R; Gabbai FB; Provenzano M; Chiodini P; Borrelli S; Garofalo C; Sasso FC; Santoro D; Bellizzi V; Conte G; De Nicola L
    Nephrol Dial Transplant; 2018 Nov; 33(11):1942-1949. PubMed ID: 29509925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance of CKD-EPI equation to estimate glomerular filtration rate as compared to MDRD equation in South Brazilian individuals in each stage of renal function.
    Veronese FV; Gomes EC; Chanan J; Carraro MA; Camargo EG; Soares AA; Thomé FS; Silveiro SP
    Clin Chem Lab Med; 2014 Dec; 52(12):1747-54. PubMed ID: 24940711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of routine reporting of estimated glomerular filtration rate using the CKD-EPI formula in a community population: A cross-sectional cohort study.
    Mitchell T; Hadlow N; Chakera A
    Nephrology (Carlton); 2014 Sep; 19(9):581-6. PubMed ID: 24888643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL; Polkinghorne KR; Atkins RC; Chadban SJ
    Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Food Insecurity, CKD, and Subsequent ESRD in US Adults.
    Banerjee T; Crews DC; Wesson DE; Dharmarajan S; Saran R; Ríos Burrows N; Saydah S; Powe NR;
    Am J Kidney Dis; 2017 Jul; 70(1):38-47. PubMed ID: 28215947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic kidney disease and prognosis in elderly patients with cardiovascular disease: Comparison between CKD-EPI and Berlin Initiative Study-1 formulas.
    Tarantini L; McAlister FA; Barbati G; Ezekowitz JA; Cioffi G; Faggiano P; Pulignano G; Cherubini A; Grisolia Franceschini E; Di Lenarda A
    Eur J Prev Cardiol; 2016 Sep; 23(14):1504-13. PubMed ID: 26988974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined diabetes-renal multifactorial intervention in patients with advanced diabetic nephropathy: Proof-of-concept.
    Fogelfeld L; Hart P; Miernik J; Ko J; Calvin D; Tahsin B; Adhami A; Mehrotra R; Fogg L
    J Diabetes Complications; 2017 Mar; 31(3):624-630. PubMed ID: 28041817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR.
    Matsushita K; Tonelli M; Lloyd A; Levey AS; Coresh J; Hemmelgarn BR;
    Am J Kidney Dis; 2012 Aug; 60(2):241-9. PubMed ID: 22560843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study.
    Jesky MD; Dutton M; Dasgupta I; Yadav P; Ng KP; Fenton A; Kyte D; Ferro CJ; Calvert M; Cockwell P; Stringer SJ
    PLoS One; 2016; 11(11):e0165675. PubMed ID: 27832126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Orlandi PF; Fujii N; Roy J; Chen HY; Lee Hamm L; Sondheimer JH; He J; Fischer MJ; Rincon-Choles H; Krishnan G; Townsend R; Shafi T; Hsu CY; Kusek JW; Daugirdas JT; Feldman HI;
    BMC Nephrol; 2018 Jun; 19(1):150. PubMed ID: 29940877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study.
    Chinnadurai R; Clarke NW; Kalra PA
    BMC Nephrol; 2020 May; 21(1):202. PubMed ID: 32471368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients.
    Ibrahim F; Hamzah L; Jones R; Nitsch D; Sabin C; Post FA;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2291-7. PubMed ID: 22121232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular death and progression to end-stage renal disease after major surgery in elderly patients.
    Lysak N; Hashemighouchani H; Davoudi A; Pourafshar N; Loftus TJ; Ruppert M; Efron PA; Rashidi P; Bihorac A; Ozrazgat-Baslanti T
    BJS Open; 2020 Feb; 4(1):145-156. PubMed ID: 32011817
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Strategy to estimate risk progression of chronic kidney disease, cardiovascular risk, and referral to nephrology: the EPIRCE Study.
    Gayoso-Diz P; Otero-González A; Rodríguez-Álvarez MX; García F; González-Quintela A; Martin de Francisco AL
    Nefrologia; 2013; 33(2):223-30. PubMed ID: 23511758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of fractures in middle-aged individuals with early chronic kidney disease: a population-based analysis of CARTaGENE.
    Desbiens LC; Goupil R; Madore F; Mac-Way F
    Nephrol Dial Transplant; 2020 Oct; 35(10):1712-1721. PubMed ID: 31951261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.
    Tabibzadeh N; Wagner S; Metzger M; Flamant M; Houillier P; Boffa JJ; Vrtovsnik F; Thervet E; Stengel B; Haymann JP;
    Am J Kidney Dis; 2019 May; 73(5):596-604. PubMed ID: 30777634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.